Abstract
Aim: To study the expression patterns and prognostic value of the m6A-associated regulators in prostate adenocarcinoma (PRAD). Materials & methods: The mRNA expression and clinical data were downloaded from ‘The Cancer Genome Atlas database’. The m6A-associated variants were downloaded from m6AVar database, and combined with 14 common m6A regulators for subsequent analysis. One-way analysis of variance, univariate Cox regression analysis and least absolute shrinkage and selection operator algorithm were successively applied to obtain the ultimate regulators and prognostic model. Finally, consensus clustering, protein–protein interaction (PPI) and enrichment analysis were performed. Result: Nine regulators were obtained. PRAD patients could be classified into two risk groups and subclasses with significant survival differences by the prognostic model and consensus clustering, respectively. Conclusion: All these nine regulators were related to prognosis in PRAD, and could be used as clinical biomarkers.
Author contributions
All authors contributed to study design and data acquisition, analysis or interpretation and drafting of this manuscript. All the authors had full access to all the data in the study and take responsibility for the integrity of the data and accuracy of data analysis.
Acknowledgements
The authors thanked the Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology and Department of Urology, First Affiliated Hospital, School of Medicine, Shihezi University.
Financial & competing interests disclosure
This work was supported by the Key scientific and technological projects of Xinjiang production and Construction Corps (2018AB023). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Ethical conduct of research
The authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations.
Data sharing statement
The data used to support the findings of this study are from the public database of The Cancer Genome Atlas (TCGA, cancergenome.nih.gov), The Genotype-Tissue Expression (GTEx, www.gtexportal.org), m6AVar (m6avar.renlab.org) and Human Protein Atlas (HPA, www.proteinatlas.org).